Polypeptide Market Discern Magnified Growth By 2028

With an increasing number of patients diagnosed with cancer, many pharmaceutical companies are conducting intensive research to discover effective anti-cancer drugs. The World Health Organization (WHO), cancer was the second leading cause of death, killing over 8.8 million people across the globe. 70% patients in low- or middle-income countries, who are diagnosed with cancer succumb to death. It generates needs for an effective oncology medicine that can reduce the number of deaths caused by cancer. Due to their chemical structure, polypeptides are used widely in treatments for cancer, especially hormone-dependent cancers, which is the main factor driving the growth of the polypeptide market.

The National Cancer Institute estimates that more than 1.73 million new cases of cancer will be diagnosed in 2018. It also predicts that around cancer will cause over 609,640 deaths in the U.S. by the end of 2018. Owing to the limitation of conventional chemotherapeutic medicines, a growing number of pharmaceutical companies are using polypeptides to manufacture medicines used in cancer therapies. Improved effectiveness of oncology medicines manufactured using polypeptides is triggering the growth of the polypeptide market. It is expected that the number of cancer survivors may increase from 15.5 million in 2016 to over 20.3 million in 2026. It is expected to boost demand for polypeptides in the pharmaceutical industry and contribute to the growth of the polypeptide market. For an instance, by making the use of right polypeptide to make anti-cancer drugs, Nano Intelligence Biomedical Engineering Corporation (NIBEC) recently acquired an anti-cancer peptide patent, named “Anti-Cancer Peptide for Inhibition of Proliferation on the Cancer Stem Cells and Use Thereof,”, in the U.S.

Get Brochure of The Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=796

Depending upon the length of clinical evaluation and new potential leads in genomics, the demand for polypeptides is expected to remain high in biotechnological and pharmaceutical applications. Its growing applications in the biomedical industry are complementing the expansion of the polypeptide market. The growth of the polypeptide is mainly attributed to the enormous interest of pharmaceutical manufacturers in antimicrobial peptides (AMPs), which play an important therapeutic role in wound healing or regeneration. When used in vaccines, polypeptides provide complete protection against various infectious diseases. Manufacturers in the polypeptides market are leveraging the chemical diversity and amino acid sequences of polypeptides to control biological cellular functions and provide more effective biomedical solutions.

Apart from the pharmaceutical industry, the cosmetics and personal care industry is likely to influence the growth of the polypeptide market in the upcoming years. Owing to the benefits of polypeptides in nourishing collagen in the human skin, polypeptide remains the most sought-after ingredient among various skincare and cosmetic manufacturers. Elemis, a luxury skincare brand, recently introduced a skincare product that, the company affirms, is ‘the next generation of anti-aging skincare’. The company used Drone Peptide Technology, which acts as a targeted delivery system to improve the skin hydration and anti-aging processes.

Get TOC of The Report: https://www.factmr.com/connectus/sample?flag=T&rep_id=796

The future prospects of the polypeptide market are influenced by the emergence of advanced technologies, and it is expected to improve its applications range in the upcoming years. Manufacturers in the polypeptides market are benefiting from technological advancements to improve the quality of their products. Nuritas, Ltd. – a leading biotechnology firm in the polypeptide market – announced that it will be using artificial intelligence algorithms along with deep learning and genomics to predict the effects of various food-derived bioactive peptides before using them. BASF SE, a German chemical company, has collaborated with Nuritas to incorporate advanced technologies like Artificial Intelligence to discover novel food and health ingredients. Nuritas also stated that it has already raised over US 20 million to discover new disease areas with the help of advanced technologies and accelerate its way to the polypeptide market. The use of advanced technologies in pharmaceutical as well as skincare applications of polypeptides can help manufacturers to consolidate a stronger position in the polypeptides market.

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.